Advancing Innovation & Outcomes for Women's Health
NAYA Women's Health, formed through the merger of NAYA Biosciences and INVO Bioscience, is building a portfolio of innovative solutions dedicated to expanding access, improving outcomes, and enhancing the patient experience in women's health.
INVOcell® is our novel, FDA-cleared and CE-marked IVC device. It offers a viable alternative to IVF that uses the female body for fertilization and incubation, keeping women at the center of the reproductive process. This unique method allows us to reduce costs, increase accessibility, and improve patient experience, providing a path to parenthood suitable for the majority of women.
INVOcell® is suitable for a majority of patients and has demonstrated comparable success rates to IVF at a fraction of the cost.
NAYA intends to rapidly expand its portfolio of innovative women's health assets.
​